Immunovant (IMVT) Profit After Tax (2018 - 2026)
Immunovant (IMVT) posted Profit After Tax of -$147.9 million for Q1 2026, down 33.64% on a QoQ basis from -$110.6 million in Q4 2025, and down 38.9% year-over-year from -$242.0 million in Q1 2025.
Immunovant (IMVT) Profit After Tax (2018 - 2026) Analysis & Trends
Immunovant's Profit After Tax history runs 9 years deep, the most recent figure standing at -$147.9 million for Q1 2026.
- Quarterly Profit After Tax fell 38.9% year-over-year to -$147.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$505.6 million (down 22.17% YoY) and the FY2026 annual result came in at -$505.6 million, down 22.17% from the prior year.
- Profit After Tax was -$147.9 million for Q1 2026 at Immunovant, down from -$110.6 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$40.4 million in Q2 2022 and bottomed at -$147.9 million in Q1 2026.
- A 5-year average of -$84.5 million and a median of -$75.3 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax rose 18.68% — and 2024, when it tumbled 116.11%.
- Immunovant's Profit After Tax stood at -$63.2 million in 2022, then grew by 18.68% to -$51.4 million in 2023, then tumbled by 116.11% to -$111.1 million in 2024, then grew by 0.44% to -$110.6 million in 2025, then sank by 33.64% to -$147.9 million in 2026.
- Business Quant data shows IMVT's Profit After Tax at -$147.9 million in Q1 2026, -$110.6 million in Q4 2025, and -$126.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -147.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147.86 Mn |
| Dec 31, 2025 | -110.64 Mn |
| Sep 30, 2025 | -126.50 Mn |
| Jun 30, 2025 | -120.61 Mn |
| Mar 31, 2025 | -106.45 Mn |
| Dec 31, 2024 | -111.12 Mn |
| Sep 30, 2024 | -109.12 Mn |
| Jun 30, 2024 | -87.15 Mn |
| Mar 31, 2024 | -75.32 Mn |
| Dec 31, 2023 | -51.42 Mn |
| Sep 30, 2023 | -58.66 Mn |
| Jun 30, 2023 | -73.94 Mn |
| Mar 31, 2023 | -59.43 Mn |
| Dec 31, 2022 | -63.23 Mn |
| Sep 30, 2022 | -47.93 Mn |
| Jun 30, 2022 | -40.37 Mn |
| Mar 31, 2022 | -47.17 Mn |
| Dec 31, 2021 | -41.39 Mn |
| Sep 30, 2021 | -37.70 Mn |
| Jun 30, 2021 | -30.47 Mn |